Personalized Therapy of Sarcomas

por Desar, Ingrid M. E., Rothermundt, Christian
Publicado 2023

Optimizing the dose in patients treated with imatinib as first line treatment for gastrointestinal stromal tumours: A cost‐effectiveness study

por Zuidema, Sander, Desar, Ingrid M.E., van Erp, Nielka P., Kievit, Wietske
Publicado 2019

Systemic Treatment for Adults with Synovial Sarcoma

por Desar, Ingrid M. E., Fleuren, Emmy D. G., van der Graaf, Winette T. A.
Publicado 2018

The complexity of sunitinib dosing in renal cell cancer patients

por Desar, Ingrid M.E., Mulder, Sasja F., Mulders, Peter F.A., van Herpen, Carla M.L.
Publicado 2012

Advanced soft-tissue sarcoma and treatment options: critical appraisal of trabectedin

por Desar, Ingrid M E, Constantinidou, Anastasia, Kaal, Suzanne E J, Jones, Robin L, van der Graaf, Winette T A
Publicado 2016

Imatinib, sunitinib and pazopanib: From flat‐fixed dosing towards a pharmacokinetically guided personalized dose

por Westerdijk, Kim, Desar, Ingrid M.E., Steeghs, Neeltje, van der Graaf, Winette T.A., van Erp, Nielka P.
Publicado 2020

Health-related quality Of Life In patients with advanced Soft TIssue sarcomas treated with Chemotherapy (The HOLISTIC study): protocol for an international observational cohort stu...

por Younger, Eugenie, Jones, Robin L, Desar, Ingrid M E, Peckitt, Clare, van der Graaf, Winette T A, Husson, Olga
Publicado 2020

Unravelling the heterogeneity of soft tissue and bone sarcoma patients’ health-related quality of life: a systematic literature review with focus on tumour location

por den Hollander, Dide, Van der Graaf, Winette T.A., Fiore, Marco, Kasper, Bernd, Singer, Susanne, Desar, Ingrid. M.E., Husson, Olga
Publicado 2020

Improved Efficacy of First-Line Imatinib in Advanced Gastrointestinal Stromal Tumors (GIST): The Dutch GIST Registry Data

por Mohammadi, Mahmoud, IJzerman, Nikki S., Hollander, Dide den, Bleckman, Roos F., Oosten, Astrid W., Desar, Ingrid M. E., Reyners, An K. L., Steeghs, Neeltje, Gelderblom, Hans
Publicado 2023

Measuring Tumour Imatinib Concentrations in Gastrointestinal Stromal Tumours: Relevant or Redundant?

por Giraud, Eline L., de Jong, Loek A. W., van den Hombergh, Erik, Kaal, Suzanne E. J., van Erp, Nielka P., Desar, Ingrid M. E.
Publicado 2023

Immunohistochemical selection of biomarkers for tumor-targeted image-guided surgery of myxofibrosarcoma

por de Gooyer, Jan Marie, Versleijen-Jonkers, Yvonne M. H., Hillebrandt-Roeffen, Melissa H. S., Frielink, Cathelijne, Desar, Ingrid M. E., de Wilt, Johannes H. W., Flucke, Uta, Rijpkema, Mark
Publicado 2020

Factors influencing the quality and functioning of oncological multidisciplinary team meetings: results of a systematic review

por Walraven, Janneke E. W., van der Hel, Olga L., van der Hoeven, J. J. M., Lemmens, Valery E. P. P., Verhoeven, Rob H. A., Desar, Ingrid M. E.
Publicado 2022

Dutch Gastrointestinal Stromal Tumor (GIST) Registry Data Comparing Sunitinib with Imatinib Dose Escalation in Second-Line Advanced Non-KIT Exon 9 Mutated GIST Patients

por Mohammadi, Mahmoud, Jansen-Werkhoven, Thekla M., Ijzerman, Nikki S., den Hollander, Dide, Bleckman, Roos F., Oosten, Astrid W., Desar, Ingrid M. E., Reyners, An K. L., Steeghs, Neeltje, Gelderblom, Hans
Publicado 2022

Pros and cons of streamlining and use of computerised clinical decision support systems to future-proof oncological multidisciplinary team meetings

por Walraven, Janneke E. W., Verhoeven, Rob H. A., van der Hoeven, Jacobus J. M., van der Meulen, Renske, Lemmens, Valery E. P. P., Hesselink, Gijs, Desar, Ingrid M. E.
Publicado 2023

(18)F-FLT-PET for Response Evaluation of MEK Inhibitor Selumetinib (AZD6244, ARRY-142886) in Patients with Solid Tumors

por Desar, Ingrid M. E., Gilles, Rozemarie, van Herpen, Carla M. L., Timmer-Bonte, Anja (J.) N. H., Cantarini, Mireille V., van der Graaf, Winette T. A., Oyen, Wim J. G.
Publicado 2012

Preparing tomorrow’s medical specialists for participating in oncological multidisciplinary team meetings: perceived barriers, facilitators and training needs

por Walraven, Janneke E. W., van der Meulen, Renske, van der Hoeven, Jacobus J. M., Lemmens, Valery E. P. P., Verhoeven, Rob H. A., Hesselink, Gijs, Desar, Ingrid M. E.
Publicado 2022

The relationship between sunitinib exposure and both efficacy and toxicity in real‐world patients with renal cell carcinoma and gastrointestinal stromal tumour

por Westerdijk, Kim, Krens, Stefanie D., van der Graaf, Winette T.A., Mulder, Sasja F., van Herpen, Carla M.L., Smilde, Tineke, van Erp, Nielka P., Desar, Ingrid M.E.
Publicado 2020

Facilitators and barriers to conducting an efficient, competent and high-quality oncological multidisciplinary team meeting

por Walraven, Janneke E W, Verhoeven, Rob H A, van der Meulen, Renske, van der Hoeven, Jacobus J M, Lemmens, Valery E P P, Hesselink, Gijs, Desar, Ingrid M E
Publicado 2023

Exposure‐toxicity relationship of cabozantinib in patients with renal cell cancer and salivary gland cancer

por Krens, Stefanie D., van Boxtel, Wim, Uijen, Maike J. M., Jansman, Frank G. A., Desar, Ingrid M. E., Mulder, Sasja F., van Herpen, Carla M. L., van Erp, Nielka P.
Publicado 2021

Prognostic Factors in a Large Nationwide Cohort of Histologically Confirmed Primary and Secondary Angiosarcomas

por Weidema, Marije E., Flucke, Uta E., van der Graaf, Winette T.A., Ho, Vincent K.Y., Hillebrandt-Roeffen, Melissa H.S., Versleijen-Jonkers, Yvonne M.H., Husson, Olga, Desar, Ingrid M.E.
Publicado 2019